Deficiencies in the Fanconi Anemia DNA Damage Response Pathway Increase Sensitivity to HPV-Associated Head and Neck Cancer
Open Access
- 1 December 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (23) , 9959-9968
Abstract
Patients with the rare genetic disease, Fanconi anemia (FA), are highly susceptible to squamous cell carcinomas arising at multiple anatomic sites including the head and neck region. Human papillomaviruses (HPVs), particularly HPV16, are associated with ∼20% of head and neck squamous cell carcinomas (HNSCCs) in the general population. Some but not other investigators have reported that HNSCCs in FA patients are much more frequently positive for HPV. In addition, studies have demonstrated an interaction between the HPV16 E7 oncoprotein and the FA pathway, a DNA damage response pathway deficient in FA patients. On the basis of these studies, it was hypothesized that the FA pathway contributes to repair of DNA damage induced by HPV16 E7, providing one explanation for why FA patients are predisposed to HPV-associated HNSCCs. To determine the importance of the FA pathway in modulating the oncogenic abilities of E7, we crossed K14E7 transgenic (K14E7) and fancD2 knockout mice (FancD2−/−) to establish K14E7/FancD2−/− and K14E7/FancD2+/+ mice and monitored their susceptibility to HNSCC when treated with a chemical carcinogen. K14E7/FancD2−/− mice had a significantly higher incidence of HNSCC compared with K14E7/FancD2+/+ mice. This difference correlated with an increased proliferative index and the increase in expression of biomarkers that are used to assess levels of DNA damage. These animal studies support the hypotheses that FA patients have increased susceptibility to HPV-associated cancer and that the FA DNA damage response pathway normally attenuates the oncogenic potential of HPV16 E7. Cancer Res; 70(23); 9959–68. ©2010 AACR.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in miceVirology, 2010
- How the Fanconi Anemia Pathway Guards the GenomeAnnual Review of Genetics, 2009
- Clinical and Molecular Characteristics of Squamous Cell Carcinomas From Fanconi Anemia PatientsJNCI: Journal of the National Cancer Institute, 2008
- Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft cultureOncogene, 2008
- Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathwayOncogene, 2008
- Role of Rb-Dependent and Rb-Independent Functions of Papillomavirus E7 Oncogene in Head and Neck CancerCancer Research, 2007
- The Human Papillomavirus Type 16 E7 Oncoprotein Activates the Fanconi Anemia (FA) Pathway and Causes Accelerated Chromosomal Instability in FA CellsJournal of Virology, 2007
- Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical CancersCancer Research, 2007
- Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse modelProceedings of the National Academy of Sciences, 2006
- Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instabilityOncogene, 2002